Relationship between p53 status and the bioeffect of ionizing radiation

X Kong, D Yu, Z Wang, S Li - Oncology letters, 2021 - spandidos-publications.com
Radiotherapy is widely used in the clinical treatment of cancer patients and it may be used
alone or in combination with surgery or chemotherapy to inhibit tumor development …

Extracellular Matrix Proteins Confer Cell Adhesion-Mediated Drug Resistance Through Integrin αv in Glioblastoma Cells

Q Yu, W Xiao, S Sun, A Sohrabi, J Liang… - Frontiers in cell and …, 2021 - frontiersin.org
Chemotherapy resistance to glioblastoma (GBM) remains an obstacle that is difficult to
overcome, leading to poor prognosis of GBM patients. Many previous studies have focused …

[HTML][HTML] Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53

B Song, J Wang, Y Ren, Y Su, X Geng, F Yang… - Biomedicine & …, 2023 - Elsevier
Abstract p53 is a transcription factor that activates the expression of various genes involved
in the maintenance of genomic stability, and more than 50% of cancers harbor inactivating …

CF3‐pyridinyl substitution on antimalarial therapeutics: probing differential ligand binding and dynamical inhibitory effects of a novel triazolopyrimidine‐based inhibitor …

C Agoni, EY Salifu, G Munsamy, FA Olotu… - Chemistry & …, 2019 - Wiley Online Library
The quest for reliable dihydroorotate dehydrogenase (DHODH) inhibitors has engendered
the discovery of potential therapeutic compounds at different stages of clinical trials …

[HTML][HTML] Does size really matter? Probing the efficacy of structural reduction in the optimization of bioderived compounds–A computational “proof-of-concept”

FA Olotu, G Munsamy, MES Soliman - Computational and Structural …, 2018 - Elsevier
Over the years, numerous synthetic approaches have been utilized in drug design to
improve the pharmacological properties of naturally derived compounds and most …

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice

D Chai, X Wang, P Neeli, S Zhou, X Yu, K Sabapathy… - Genes & …, 2024 - Elsevier
The tumor suppressor p53 is the most common mutated gene in cancer, with the R175H as
the most frequent p53 missense mutant. However, there are currently no approved targeted …

Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives

EY Salifu, C Agoni, FA Olotu, MES Soliman - Computational Biology and …, 2020 - Elsevier
Bedaquiline (BDQ) has demonstrated formidable bactericidal activity towards
Mycobacterium tuberculosis (Mtb) in the treatment of multi-drug resistant (MDR) and …

Exploration of alternate therapeutic remedies in Ebola virus disease: the case of reported antiviral phytochemical derived from the leaves Spondias Mombin Linn

A Boadu, R Karpoormath, M Nlooto - Advances in Traditional Medicine, 2023 - Springer
The most common and lethal of the six strains of Ebola viruses (EBOV) causing the
Ebolavirus disease is the Zaire EBOV and has an approximately 90% mortality rate of …

Deciphering the 'Elixir of Life': Dynamic perspectives into the allosteric modulation of mitochondrial ATP synthase by J147, a novel drug in the treatment of Alzheimer's …

IA Emmanuel, FA Olotu, C Agoni… - Chemistry & …, 2019 - Wiley Online Library
The discovery of J147 represented a significant milestone in the treatment of age‐related
disorders, which was further augmented by the recent identification of mitochondrial ATP …

Halting ionic shuttle to disrupt the synthetic machinery—Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis …

EY Salifu, C Agoni, FA Olotu… - Journal of Cellular …, 2019 - Wiley Online Library
Therapeutic targeting of the adenosine triphosphate (ATP) machinery of Mycobacterium
tuberculosis (Mtb) has recently presented a potent and alternative measure to halt the …